New combo therapy for head and neck cancer: what about the skin?
NCT ID NCT01647555
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at skin problems in 57 patients with advanced head and neck cancer who received a combination of the drug cetuximab and radiation therapy. The goal was to track and understand skin side effects during treatment. Researchers also measured quality of life and tumor response, but the main focus was on managing skin reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cetuximab
- What this could lead to
- If successful, this could help doctors better manage skin side effects from this combination treatment, improving patient comfort during therapy.
- What could go wrong
- This is a small, completed study focused only on side effects, not on whether the treatment works better than alternatives. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPIDERMOID HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Bourgogne
Lille, 59000, France
-
Centre Galilée
Lille, 59045, France
-
Centre Gray
Maubeuge, 59600, France
-
Centre Joliot Curie
Saint-Martin-Boulogne, 62280, France
-
Centre Leonard de Vinci
Douai, 59500, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Clinique du Parc
Croix, 599962, France